---
schema_version: "secwatch.filing_event.v1"
accession: "0001510964-23-000012"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2023-03-29T23:59:59+00:00"
generated_at: "2026-06-17T10:19:16.079823+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CV Sciences FY2022 revenue $16.2M, down 19% YoY; operating loss narrows to $6.8M

## Summary
- Revenue $16.2M for FY2022 vs $20.0M in 2021 (-19%); Q4 revenue $3.9M, up 3% sequentially.
- Gross margin 34.2% in FY2022 vs 43.0% in 2021; Q4 gross margin 40.4%.
- Operating expenses cut 54% to $12.4M; operating loss improved to $6.8M from $18.4M.
- Cash balance $0.6M at year-end; Q4 generated $0.2M positive operating cash flow.
- Regained #1 hemp extract brand in natural retail; launched new products; evaluating M&A.

## SEC filing metadata
- accession: 0001510964-23-000012
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2023-03-29T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000151096423000012/0001510964-23-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000151096423000012/cvsi-20230329.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001510964-23-000012
- JSON: https://secwatch.observer/filing/0001510964-23-000012.json
- Plain text: https://secwatch.observer/filing/0001510964-23-000012.txt

## Key facts
- Earnings Releases
  CV Sciences, Inc. reported the year and quarter ended December 31, 2022 results: revenue $16.2 million.
  - Period: the year and quarter ended December 31, 2022
  - Revenue: $16.2 million
  - Result: reported results
  source text: its financial results for the year and quarter ended December 31, 2022. Fiscal 2022, Fourth Quarter 2022 and Recent Financial and Operating Highlights • Generated revenue of $16.2 million for fiscal year 2022 compared to $20.0 million for 2021; Revenue of $3.9 million for the fourth quarter 2022 sequential increase of 3% from $3.8 million in the third quarter
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000151096423000012/0001510964-23-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.